S5 File - by Marian Adan (16641634)

S3 File - by Marian Adan (16641634)

S1 File - by Marian Adan (16641634)

S6 File - by Marian Adan (16641634)

S2 File - by Marian Adan (16641634)

S4 File - by Marian Adan (16641634)

MeV <i>M</i> mRNA quantification in cells treated with an inhibitor of RNA polymerase III. by Pierre Khalfi (7868252)

Heterodimerization of MC1R and MC1R-TUBB3 chimeric isoforms. by Cecilia Herraiz (836697)

FOXM1 increases transcription of <i>AGR2</i> and is required to maintain mucinous phenotype in PIMAs. by David Milewski (4710029)

“…<b>(D)</b> Inhibition of FOXM1 reduces mucus depositions shown with Alcian Blue, and <b>(E)</b> reduces AGR2 and MUC5AC expression in A549 orthotopic xenografts. AGR2 co-localizes with MUC5Ac in the orthotopic A549 xenografts. 5–8 images per mouse lung were used. …”

Mesh partitioning results. by Hang Chen (23866)

GM Mask image count after preprocessing. by Muhammad Zubair (728141)

Architecture of Multi-EfficientNet. by Muhammad Zubair (728141)

Average Saliency Map Results. by Muhammad Zubair (728141)

Original dataset composition (Raw from ADNI). by Muhammad Zubair (728141)

Class-wise performance on the test set. by Muhammad Zubair (728141)

Details of Hyperparameters. by Muhammad Zubair (728141)

<i>N</i>. <i>bombycis</i> coated with BmVg in infected ovarioles. by Chunxia Wang (766713)

Ablation Study Result. by Muhammad Zubair (728141)

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”